← back to search

Hongzhen Zhang

Hebei Medical University · CN
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Cancer, Hypoxia, and Metabolism, MicroRNA in disease regulation, Chinese history and philosophy, and Circular RNAs in diseases.
h-index
13
citations
743
works
70
NIH funding
primary concept
email

Recent publications

Impact of gut microbiota dysbiosis on intestinal barrier integrity and systemic inflammation in a pre-eclampsia mouse model
Microbial Pathogenesis 2025cited by 3position: lastdoi
Gut Microbiota Dysbiosis in Preeclampsia: Mechanisms, Biomarkers, and Probiotic‐Based Interventions
Mediators of Inflammation 2025cited by 2position: lastdoi
USP7 promotes cervical cancer progression by stabilizing MTDH expression through deubiquitination
Journal of Cancer Research and Clinical Oncology 2024cited by 6position: lastdoi
The effect of gut microbiota dysbiosis on patients with preeclampsia
Frontiers in Cellular and Infection Microbiology 2023cited by 29position: lastdoi
MiR-214-3p suppresses cervical cancer cell metastasis by downregulating THBS2
Cellular and Molecular Biology 2023cited by 10position: middledoi
Causal association between lipid-lowering drugs and female reproductive endocrine diseases: a drug-targeted Mendelian randomization study
Frontiers in Endocrinology 2023cited by 6position: lastdoi
Identification of <scp>N1</scp> methyladenosine‐related biomarker predicting overall survival outcomes and experimental verification in ovarian cancer
Journal of obstetrics and gynaecology research 2023cited by 3position: lastdoi
Corrigendum: The effect of gut microbiota dysbiosis on patients with preeclampsia
Frontiers in Cellular and Infection Microbiology 2023cited by 0position: lastdoi
Evaluation of Short-Term Efficacy of Concurrent Chemoradiotherapy in Primary Fallopian Tube Carcinoma by Diffusion-Weighted Imaging: A Retrospective Study
Oncology Research and Treatment 2017cited by 2position: middledoi
Lipoic acid protects dopaminergic neurons in LPS-induced Parkinson’s disease model
Metabolic Brain Disease 2015cited by 49position: middledoi
Expression and clinical significance of FXYD3 in endometrial cancer
Oncology Letters 2014cited by 30position: middledoi
The Therapeutic Potential of Rho Kinase Inhibitor Fasudil Derivative FaD-1 in Experimental Autoimmune Encephalomyelitis
Journal of Molecular Neuroscience 2014cited by 15position: middledoi
Tracking in vivo migration and distribution of antigen-specific cytotoxic T lymphocytes by 5,6-carboxyfluorescein diacetate succinimidyl ester staining during cancer immunotherapy
Chinese Medical Journal 2013cited by 5position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Bingjie Wang · Peking University4 papers (2023–2025)Shaoke Hou · Hebei Medical University4 papers (2023–2025)Dan Cui · Shanghai East Hospital4 papers (2023–2025)Yefang Zhao · Hebei Medical University4 papers (2023–2025)Gui-Ying Fang · Hebei Medical University3 papers (2014–2023)Ruiping Wang · Institute of Computing Technology2 papers (2025–2025)Yunxia Zhang · Union Hospital2 papers (2023–2023)Hua Han · Zhejiang University2 papers (2023–2023)Jing Zhao · Guizhou University2 papers (2023–2023)Jing Ge · Nanjing University of Chinese Medicine2 papers (2014–2017)Jie‐Zhong Yu · Shanxi Medical University2 papers (2014–2015)Zongxu Qiao · Hebei Medical University2 papers (2025–2025)Xujing Wei · Hebei Medical University2 papers (2025–2025)Bao‐Guo Xiao · Fudan University2 papers (2014–2015)Dengxiang Liu · Hebei Medical University2 papers (2025–2025)Runfang Wang · Hebei General Hospital2 papers (2023–2023)Chunyun Liu · Xiamen University2 papers (2014–2015)Hui Zhang · Shanxi Medical University1 papers (2014–2014)Bei Wang · Jiangsu University1 papers (2023–2023)Yifei Li · Chinese Academy of Sciences1 papers (2014–2014)